Other potential disorders suitable for allele-specific treatment include dystonia, in which a three-base pair deletion has been identified in the mutant torsinA gene product [21] and point mutations in the superoxide dismutase gene have been implicated in familial forms of amyotrophic lateral sclerosis (ALS) [22]. The gene discussed is TOR1A; the disease is amyotrophic lateral sclerosis.